KUROS BIOSCIENCES AG

KURN
Delayed Quote. Delayed  - 10/26 12:30:02 pm
2.05CHF +4.86%
Prev.1.9550
Open2.0000
High2.0900
Low2.0000
Volume137 427
Latest news
6d ago
6d ago
6d ago
6d ago
Chart KUROS BIOSCIENCES AG
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance2,152,662,82
Spread/Res.-4,5%-23%-27%
Spread/Supp.8,2%17%20%
Support1,901,751,70
Financials
Sales 2019 2,56 M 2,82 M 2,82 M
Net income 2019 -11,3 M -12,4 M -12,4 M
Net cash 2019 18,4 M 20,3 M 20,3 M
P/E ratio 2019 -3,45x
Yield 2019 -
Capitalization 54,7 M 60,3 M 60,3 M
EV / Sales 2018 22,7x
EV / Sales 2019 14,3x
Nbr of Employees 45
Free-Float 74,6%
Company
Kuros Biosciences AG is a Switzerland-based biotechnology company engaged in the discovery, development and commercialization of biopharmaceutical products known as Immunodrugs. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension,...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-04-28 Earnings Release

Income Statement Evolution